Within our group of canonical driver mutations, we found that (with the exception of KRAS and TP53) there is a consistent and high level of mutual exclusivity between canonical driver genes, suggesting that the recurrent mutations found across studies are not interdependent for ICC initiation and growth (Fig. 1E). This evidence concerns the gene KRAS and intrahepatic cholangiocarcinoma.